KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Interest Coverage Ratio (2023 - 2025)

Historic Interest Coverage Ratio for Travere Therapeutics (TVTX) over the last 9 years, with Q3 2025 value amounting to 8.9.

  • Travere Therapeutics' Interest Coverage Ratio rose 14440.15% to 8.9 in Q3 2025 from the same period last year, while for Sep 2025 it was 8.03, marking a year-over-year increase of 7477.74%. This contributed to the annual value of 28.91 for FY2024, which is 1557.09% up from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Interest Coverage Ratio is 8.9, which was up 14440.15% from 4.44 recorded in Q2 2025.
  • Travere Therapeutics' Interest Coverage Ratio's 5-year high stood at 8.9 during Q3 2025, with a 5-year trough of 49.73 in Q1 2024.
  • Its 3-year average for Interest Coverage Ratio is 22.87, with a median of 22.94 in 2024.
  • As far as peak fluctuations go, Travere Therapeutics' Interest Coverage Ratio soared by 3386.91% in 2024, and later soared by 14440.15% in 2025.
  • Quarter analysis of 3 years shows Travere Therapeutics' Interest Coverage Ratio stood at 33.4 in 2023, then soared by 35.06% to 21.69 in 2024, then soared by 141.05% to 8.9 in 2025.
  • Its Interest Coverage Ratio stands at 8.9 for Q3 2025, versus 4.44 for Q2 2025 and 14.72 for Q1 2025.